Today, PhRMA released a new resource on biopharmaceuticals in government programs. This new chart pack features key facts about prescription medicines in four major government programs – Medicare, Medicaid, Veterans Affairs and the 340B drug discount program.
Check out the chart pack here: http://www.phrma.org/gov-chartpack-2015
Below is a preview of the new resource.
Federal Spending on Health Care
Over the Next Decade:
![fed-spending-healtchare](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/fed-spending-healtchare.png)
Medicines in Medicare Part D
Beneficiaries Save Through Plan Competition and Manufacturer Negotiations
![beneficiaries-save](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/beneficiaries-save.png)
Medicines in Medicare Part B
Program Spending on Prescription Medicines Accounted for About 8% of Part B Spending in 2012
![part-b-expenditures](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/part-b-expenditures.png)
Medicines in Medicaid
On Average, About 60% of the Initial Cost of Brand Medicines is Returned to States Through Rebates
![medicaid_costs](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/medicaid_costs.png)
Medicines in Veterans Affairs
VA Formulary Covers Fewer Drugs Than Part D
![va-formularies](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/va-formularies.png)
Medicines in 340B
Without Significant Reforms 340B Will Continue to Grow as Uninsured Rate Declines
![uninsured-declines](/-/media/Project/PhRMA/PhRMA-Org/HubspotImages/hubfs/464546/uninsured-declines.png)
Check out PhRMA’s other chart pack resources here and check back with our Medicare Monday series and 340B Spotlight as we take a deeper look at some of these charts in the coming weeks.